These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32926375)

  • 21. CRISPR-Cas bioinformatics.
    Alkhnbashi OS; Meier T; Mitrofanov A; Backofen R; Voß B
    Methods; 2020 Feb; 172():3-11. PubMed ID: 31326596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M; Concordet JP
    J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR.
    Haeussler M; Schönig K; Eckert H; Eschstruth A; Mianné J; Renaud JB; Schneider-Maunoury S; Shkumatava A; Teboul L; Kent J; Joly JS; Concordet JP
    Genome Biol; 2016 Jul; 17(1):148. PubMed ID: 27380939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
    Wang Q; Ui-Tei K
    Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and analysis of CRISPR-Cas experiments.
    Hanna RE; Doench JG
    Nat Biotechnol; 2020 Jul; 38(7):813-823. PubMed ID: 32284587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid Whole-Genome Identification of High Quality CRISPR Guide RNAs with the Crackling Method.
    Bradford J; Chappell T; Perrin D
    CRISPR J; 2022 Jun; 5(3):410-421. PubMed ID: 35686976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
    Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
    Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity.
    Höijer I; Johansson J; Gudmundsson S; Chin CS; Bunikis I; Häggqvist S; Emmanouilidou A; Wilbe M; den Hoed M; Bondeson ML; Feuk L; Gyllensten U; Ameur A
    Genome Biol; 2020 Dec; 21(1):290. PubMed ID: 33261648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational Tools and Resources Supporting CRISPR-Cas Experiments.
    Sledzinski P; Nowaczyk M; Olejniczak M
    Cells; 2020 May; 9(5):. PubMed ID: 32455882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
    Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
    Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PnB Designer: a web application to design prime and base editor guide RNAs for animals and plants.
    Siegner SM; Karasu ME; Schröder MS; Kontarakis Z; Corn JE
    BMC Bioinformatics; 2021 Mar; 22(1):101. PubMed ID: 33653259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Bioinformatics Tools to Optimize CRISPR/Cas9 Experiments to Reduce Off-Target Effects.
    Naeem M; Alkhnbashi OS
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of off-target specificity and cell-specific fitness of CRISPR-Cas System using attention boosted deep learning and network-based gene feature.
    Liu Q; He D; Xie L
    PLoS Comput Biol; 2019 Oct; 15(10):e1007480. PubMed ID: 31658261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GuideMaker: Software to design CRISPR-Cas guide RNA pools in non-model genomes.
    Poudel R; Rodriguez LT; Reisch CR; Rivers AR
    Gigascience; 2022 Apr; 11():. PubMed ID: 35365834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs.
    Rose JC; Popp NA; Richardson CD; Stephany JJ; Mathieu J; Wei CT; Corn JE; Maly DJ; Fowler DM
    Nat Commun; 2020 Jun; 11(1):2697. PubMed ID: 32483117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breaking-Cas-interactive design of guide RNAs for CRISPR-Cas experiments for ENSEMBL genomes.
    Oliveros JC; Franch M; Tabas-Madrid D; San-León D; Montoliu L; Cubas P; Pazos F
    Nucleic Acids Res; 2016 Jul; 44(W1):W267-71. PubMed ID: 27166368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPRCasTyper: Automated Identification, Annotation, and Classification of CRISPR-Cas Loci.
    Russel J; Pinilla-Redondo R; Mayo-Muñoz D; Shah SA; Sørensen SJ
    CRISPR J; 2020 Dec; 3(6):462-469. PubMed ID: 33275853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPRedict: a CRISPR-Cas9 web tool for interpretable efficiency predictions.
    Konstantakos V; Nentidis A; Krithara A; Paliouras G
    Nucleic Acids Res; 2022 Jul; 50(W1):W191-W198. PubMed ID: 35670672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cas-analyzer: an online tool for assessing genome editing results using NGS data.
    Park J; Lim K; Kim JS; Bae S
    Bioinformatics; 2017 Jan; 33(2):286-288. PubMed ID: 27559154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.